RobertFreedmanMD

Professor, Department of Psychiatry and Pharmacology, University of Colorado Denver. Psychiatrist, Denver VA Medical Center. Medical Director, VA Center for Clinical and Neurobiological Investigations in Schizophrenia, Denver, CO.

Join to view full profile

Dr. Freedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Freedman's full profile

Already have an account?

Office
Mail Stop F546
Aurora, CO 80045

Education & Training

University of ChicagoResidency, Psychiatry, 1975 - 1978
Boston University Medical CenterInternship, Internal Medicine, 1972 - 1973
Harvard Medical SchoolClass of 1972

Certifications & Licensure

IL State Medical License 1976 - Present
CO State Medical License 1978 - 2025
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Elected Member Institute of Medicine, 2004
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Phase 2 Trial of a Nicotinic Agonist in Schizophrenia Start of enrollment: 2005 Jan 01
Completed
Phase 2
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes Start of enrollment: 2004 Jan 01
Completed
Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients Start of enrollment: 2004 Mar 01
Completed
Phase 1
Nicotinic Receptors and Schizophrenia Start of enrollment: 2010 Jan 01
Completed
Phase 1
Nicotinic Receptors and Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 2
Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects Start of enrollment: 2013 Jun 01
Terminated
Phase 1
Phase I Nicotinic Agonist Treatment Trial for Autism Start of enrollment: 2015 Jun 01
Terminated
Phase 1
Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal Start of enrollment: 2017 Jun 12
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

1017 citations
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Vassily Trubetskoy, Antonio F Pardiñas, Ting Qi, Georgia Panagiotaropoulou, Swapnil Awasthi
Nature. 2022-04-01
5369 citations
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke, Benjamin M. Neale, Aiden Corvin, James T.R. Walters, Kai-How Farh
Nature. 2014-07-24
790 citations
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson, Jian Yang, Hilary K. Finucane, Alexander Gusev, Sara Lindström
American Journal of Human Genetics. 2015-10-01

Journal Articles

American Psychiatric Association Publishing
Robert Freedman, MD, National Institutes of Health

Press Mentions

Ninth Season of Healthy Minds with Dr. Jeffrey Borenstein Premieres on PBS.org During Mental Health Awareness Month in MayApril 30th, 2024
Ketamine Shows Promise for Hard-to-Treat Depression in New StudyMay 26th, 2023
Ketamine Is Comparable to ECT for Patients with Treatment-Resistant Depression, Study ShowsMay 24th, 2023
Join now to see all